David Joseph Gaffin (EVP, CLO, Alkermes, Inc.) sold ~$98K of Alkermes plc
Scheduled in advanceTraded Aug 17, 2026 · Filed Aug 17, 2026
Alkermes's SVP, Chief Commercial Officer sold $33K of Alkermes shares. The filing says it was made under a pre-arranged trading plan.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
open market sale
Code S — open-market or private sale
~$32,969
Shares × reported transaction price
20 days after results of Jul 28, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Footnote references a pre-arranged trading plan (Rule 10b5-1)
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | −0.6% | −0.2% | −0.3% |
| 30 days | −5.6% | −0.6% | −5.0% |
Past results only. Not a forecast.
David Joseph Gaffin (EVP, CLO, Alkermes, Inc.) sold ~$98K of Alkermes plc
Scheduled in advanceTraded Sep 1 · filed the same day
Derivative exercise or conversion — not an open-market buy.
Craig C. Hopkinson (EVP R&D, Chief Medical Officer) sold ~$423K of Alkermes plc
Scheduled in advance